Increase in the prevalence of Parkinson’s disease is expected to drive the growth of India carbidopa market during the forecast period. According to TechSci Research report, “India Carbidopa Market By Composition (Single, Combinational), By Rate of Drug Delivery (Immediate v/s Sustained Release), By Dose (10 mg, 25mg, 50 mg, 100 mg, 250 mg, Others), By Source (In-house v/s